Some people believe that the benefits of Invokana are not worth the associated risks.
Invokana Injury Claims on the Rise as Ketoacidosis Cases Increase
Just this May, the Food and Drug Administration published a warning about a class of Type 2 diabetes medication called SGLT2 inhibitors.